Cedric Bogaert

Cedric Bogaert is a Co-Founder and CEO at myNEO Therapeutics since January 2019, a biopharmaceutical company focused on developing innovative immunotherapies to combat cancer. Cedric is also a Co-Founder at Persomed life sciences since January 2020, working on personalized neoantigen-driven DC vaccines for colorectal cancer patients. Previously, Cedric worked as a Business&Integration Arch Senior Analyst at Accenture from January 2018 to January 2019. With a background in Bio Engineering and a strong focus on genetics, Cedric is known for their expertise in developing immunovaccines and utilizing innovative technology in the field.